Results 211 to 220 of about 89,054 (257)
Some of the next articles are maybe not open access.
Scandinavian Journal of Gastroenterology, 1991
Helicobacter pylori is a unique pathogen and the leading cause of chronic gastric inflammation. For many individuals the organism is of low virulence, causing only mild inflammation and generating few, if any, dyspeptic symptoms. For those with more severe inflammation, H. pylori infection may be causal in the generation of dyspeptic symptoms.
G N, Tytgat, L, Noach, E A, Rauws
openaire +2 more sources
Helicobacter pylori is a unique pathogen and the leading cause of chronic gastric inflammation. For many individuals the organism is of low virulence, causing only mild inflammation and generating few, if any, dyspeptic symptoms. For those with more severe inflammation, H. pylori infection may be causal in the generation of dyspeptic symptoms.
G N, Tytgat, L, Noach, E A, Rauws
openaire +2 more sources
Der Gastroenterologe, 2009
Helicobacter pylori is associated with various gastroduodenal diseases such as peptic ulcer, functional dyspepsia, MALT lymphoma and distal gastric cancer. Diagnosis of H. pylori can be established by non-invasive ((13C)urea breath test, stool antigen test, serology) and invasive (histology, rapid urease test, culture) tests.
openaire +2 more sources
Helicobacter pylori is associated with various gastroduodenal diseases such as peptic ulcer, functional dyspepsia, MALT lymphoma and distal gastric cancer. Diagnosis of H. pylori can be established by non-invasive ((13C)urea breath test, stool antigen test, serology) and invasive (histology, rapid urease test, culture) tests.
openaire +2 more sources
Lipid A in Helicobacter pylori
Infection and Immunity, 1992Free lipid A of Helicobacter pylori was characterized with regard to chemical composition, reactivity with anti-lipid A antibodies, and activity in a Limulus lysate assay. The predominant fatty acids of H. pylori lipid A were 3-OH-18:0, 18:0, 3-OH-16:0, 16:0, and 14:0.
I, Mattsby-Baltzer +4 more
openaire +2 more sources
Current Treatment Options in Gastroenterology, 1999
All infected patients with a peptic ulcer should be treated for H. pylori. The role of treating H. pylori in patients with undiagnosed dyspepsia or non-ulcer dyspepsia, those taking nonsteroidal anti-inflammatory medications, or with a family history of gastric cancer remains controversial.
openaire +2 more sources
All infected patients with a peptic ulcer should be treated for H. pylori. The role of treating H. pylori in patients with undiagnosed dyspepsia or non-ulcer dyspepsia, those taking nonsteroidal anti-inflammatory medications, or with a family history of gastric cancer remains controversial.
openaire +2 more sources
Treatment of Helicobacter pylori
Best Practice & Research Clinical Gastroenterology, 2007Triple therapy, consisting of two antibiotics, clarithomycin and amoxicillin or metronidazole in combination with a proton pump inhibitor (PPI) has become the first-line option for infection with Helicobacter pylori and has been recommended at several consensus conferences.
K, Wolle, P, Malfertheiner
openaire +2 more sources
Helicobacter pylori and apoptosis
2002Publisher Summary Apoptosis associated with Helicobacter pylori (H. pylori) may be studied by one of the two approaches: either by staining human and animal gastric tissue sections, or by coculturing H. pylori with gastric cells in vitro. The advantage of a coculture system is that the target cell and bacterium may be readily manipulated, thus ...
Emilia Mia, Sordillo, Steven F, Moss
openaire +2 more sources
No Helicobacter pylori, no Helicobacter pylori‐associated peptic ulcer disease
Alimentary Pharmacology & Therapeutics, 1995SUMMARYVirtually all duodenal ulcers (DUs) and the vast majority of gastric ulcers (GUS) are the consequence of Helicobacter pylori‐associated inflammation. In DUs, the inflammation is maximal in the antrum and is associated with gastric metaplasia in the bulb. Gastrin homeostasis is disturbed by H.
openaire +3 more sources
Immunoproteome of Helicobacter pylori
2002Publisher Summary This chapter describes how two-dimensional electrophoresis (2-DE) techniques can be combined with various immunoblotting procedures and how such data sets from infected patients can be evaluated in a semiquantitative manner as a basis for the development of sensitive and specific diagnostic tests.
Jungblut, Peter R., Bumann, Dirk
openaire +4 more sources
Treatment of Helicobacter pylori
Current Opinion in Gastroenterology, 2011The article will give an overview on reasons for treatment failure and tries to show new concepts for Helicobacter pylori treatment.Several new treatment options or modifications of already established regimens have been introduced to overcome treatment failure. Antibiotic resistance to H. pylori is the key factor for treatment failure.
Michael, Selgrad, Peter, Malfertheiner
openaire +2 more sources
Journal of Antimicrobial Chemotherapy, 1993
The discovery of Helicobacter pylori is arguably the most significant advance made in gastroduodenal pathology this century. It is the most important cause of chronic gastritis, and almost certainly the major aetiological factor responsible for duodenal ulcer and probably for gastric ulcer as well.
openaire +2 more sources
The discovery of Helicobacter pylori is arguably the most significant advance made in gastroduodenal pathology this century. It is the most important cause of chronic gastritis, and almost certainly the major aetiological factor responsible for duodenal ulcer and probably for gastric ulcer as well.
openaire +2 more sources